Alphina Therapeutics
PrivateLast Round
Seed Round
Feb 23, 2026
Total Funding Raised
$40M
Company Overview
Alphina Therapeutics operates in Healthcare & Life Sciences and is based in New Haven, Connecticut. Its latest recorded funding round was a Series A round in September 2021.
Alphina Therapeutics is a biotechnology company developing small molecule inhibitors of NAMPT to treat a variety of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alphina Therapeutics Comparables
Compare Alphina Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Remedy Plan Therapeutics | 87% | |
| OncoTartis, Inc. | 81% | |
| Tessellate BIO | 76% |
For institutional investors. Book with your work email.
Alphina Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Feb 23, 2026 | ||||
| Series A | Sep 1, 2021 | ||||
| Pre Seed | Dec 15, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alphina Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A, Pre Seed |
| HighCape Capital | Series A, Pre Seed |
| Osage University Partners | Series A |
| Canaan Partners | Series A |
| Alexandria Venture Investments | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 48% month-over-month.
For institutional investors. Book with your work email.
Alphina Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alphina Therapeutics's valuation, stock price, and market status.
Is Alphina Therapeutics a public or private company?
Alphina Therapeutics is a private company.
What is the current stock price of Alphina Therapeutics?
Alphina Therapeutics is a private company, so its shares have no public market price. Caplight tracks Alphina Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alphina Therapeutics worth (valuation)?
Valuation information for Alphina Therapeutics is not publicly available.
Can I buy Alphina Therapeutics stock?
Alphina Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alphina Therapeutics's last funding round?
Alphina Therapeutics's most recent funding round was Seed Round on February 23, 2026.
Who are the main investors in Alphina Therapeutics?
Key investors in Alphina Therapeutics include Canaan Partners.
Will Alphina Therapeutics IPO soon?
No public IPO plans have been announced for Alphina Therapeutics.
How can I track Alphina Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Alphina Therapeutics's shares on secondary markets.